Literature DB >> 10861042

Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity.

D C Webb1, A N McKenzie, A M Koskinen, M Yang, J Mattes, P S Foster.   

Abstract

In this investigation, we have examined the integrated relationship between IL-13, IL-4, and IL-5 for the development of airways hyperreactivity (AHR) in a model of asthma in BALB/c mice. Sensitization and aeroallergen challenge of both wild-type (WT) and IL-13 gene-targeted (IL-13-/-) mice induced allergic disease that was characterized by pulmonary eosinophilia and AHR to beta-methacholine. Although these responses in IL-13-/- mice were heightened compared with WT, they could be reduced to the level in nonallergic mice by the concomitant neutralization of IL-4. Mice in which both IL-4 and IL-13 were depleted displayed a marked reduction in tissue eosinophils, despite the development of a blood eosinophilia. Similar neutralization of IL-4 in WT mice only partially reduced AHR with no effect on tissue eosinophilia. In addition, neutralization of IL-5 in IL-13-/- mice, but not in WT mice, inhibited AHR, suggesting that tissue eosinophilia is linked to the mechanism underlying AHR only in the absence of IL-13. Additionally, mucus hypersecretion was attenuated in IL-13-/- mice, despite the persistence of AHR. Taken together, our data suggest both a modulatory role for IL-13 during sensitization and a proinflammatory role during aeroallergen challenge. The latter process appears redundant with respect to IL-4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861042     DOI: 10.4049/jimmunol.165.1.108

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Role of IL-13 Genetic Variants in Signalling of Asthma.

Authors:  Madhavi Latha Alasandagutti; Mohd Soheb Sadat Ansari; S R Sagurthi; Vijayalakshmi Valluri; Sumanlatha Gaddam
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection.

Authors:  Antonina M Akk; Pamela M Simmons; Happy W Chan; Eugene Agapov; Michael J Holtzman; Mitchell H Grayson; Christine T N Pham
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 4.  Targeted Therapy for Severe Asthma: Identifying the Right Patients.

Authors:  Kathy Low; Philip G Bardin
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

Review 5.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

6.  Antigen 43/Fcε3 chimeric protein expressed by a novel bacterial surface expression system as an effective asthma vaccine.

Authors:  Feng-Ying Huang; Cai-Chun Wang; Yong-Hao Huang; Huan-Ge Zhao; Jun-Li Guo; Song-Lin Zhou; Hua Wang; Ying-Ying Lin; Guang-Hong Tan
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 7.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

8.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.

Authors:  Michael J Walter; Jeffrey D Morton; Naohiro Kajiwara; Eugene Agapov; Michael J Holtzman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

10.  Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.

Authors:  Ilkka S Junttila; Kiyoshi Mizukami; Harold Dickensheets; Martin Meier-Schellersheim; Hidehiro Yamane; Raymond P Donnelly; William E Paul
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.